Indaptus Therapeutics, Inc. (INDP) Ownership
INDP ownership summary
as of October 18, 2026- Institutions
- 0.3% of shares outstanding
- Insiders
- 82.41% of shares outstanding
- Shares outstanding
- 133.2M
- Float
- 23.7M shares available to trade
- Short interest
- 2.00% 822K shares short
- Days to cover
- 0.56 short interest down 10.3% vs prior month
- Institutions 0.30%
- Insiders 82.41%
- Other investors 17.28%
INDP top institutional holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | HRT FINANCIAL LLC | 0.15% | 206K | $541,983 | +206,077 (0.0%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.04% | 56K | $148,516 | +29,463 (+109.1%) | June 30, 2026 |
| 3 | Jane Street Group LLC | 0.04% | 54K | $141,523 | +53,811 (0.0%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 0.03% | 34K | $88,505 | +33,652 (0.0%) | June 30, 2026 |
| 5 | Vanguard Fiduciary Trust Co | 0.01% | 14K | $36,733 | +13,967 (0.0%) | June 30, 2026 |
| 6 | Millennium Management LLC | 0.01% | 12K | $30,471 | +11,586 (0.0%) | June 30, 2026 |
| 7 | Morgan Stanley - Brokerage Accounts | 0.01% | 8,936 | $23,502 | +6,239 (+231.3%) | June 30, 2026 |
| 8 | UBS Group AG | <0.01% | 478 | $1,257 | +478 (0.0%) | June 30, 2026 |
| 9 | SBI Securities Co Ltd | 0.00% | 17 | $45 | — | June 30, 2026 |
| 10 | CWM, LLC duplicate | 0.00% | 2 | $5 | +2 (0.0%) | March 31, 2026 |
| 11 | Tower Research Capital LLC | 0.00% | — | — | −1,890 (−100.0%) | June 30, 2026 |
| 12 | Citadel Advisors Llc | 0.00% | — | — | −39,018 (−100.0%) | June 30, 2026 |
| 13 | Bank of America Corp | 0.00% | — | — | −25 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 13, 9 holders added 355K shares and 3 cut 41K.
INDP top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.05% | 69K | $182,530 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.01% | 11K | $30,177 | — | August 31, 2026 |
| 3 | Morgan Stanley Pathway Sm-Md Cp Eq ETF | 0.01% | 11K | $29,177 | — | September 30, 2026 |
| 4 | Fidelity Series Total Market Index | <0.01% | 3,929 | $10,333 | — | August 31, 2026 |
| 5 | Fidelity Total Market Index | <0.01% | 462 | $1,215 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
INDP insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-14 | Glen R Anderson | Buy | $65.52 | 854 | $55,954 |
| 2023-08-10 | Glen R Anderson | Buy | $54.32 | 1,584 | $86,043 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
INDP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns INDP
Institutional investors own 0.3% of Indaptus Therapeutics's shares and insiders 82.41%. The largest holder is HRT FINANCIAL LLC with 0.15% of the shares (206K), as of June 30, 2026. Among the top 13 institutions, 9 added shares and 3 reduced their stake in the latest filings. Short interest is 2.00% of the float, or 0.56 days of average trading volume. The share count rose 1,414.5% since 2015.
Related: INDP analyst forecast, INDP key metrics. See the INDP stock overview for the latest quote and news.
INDP ownership FAQ
Who owns the most Indaptus Therapeutics stock?
The largest shareholders of Indaptus Therapeutics are HRT FINANCIAL LLC (0.15%), Geode Capital Management, LLC (0.04%), Jane Street Group LLC (0.04%), Vanguard Capital Management, LLC (0.03%), Vanguard Fiduciary Trust Co (0.01%).
What percentage of Indaptus Therapeutics is owned by institutions?
Institutions hold 0.3% of Indaptus Therapeutics's shares outstanding; insiders hold 82.41%.
Which funds own Indaptus Therapeutics?
The largest fund holders of Indaptus Therapeutics are Fidelity Nasdaq Composite Index (0.05%), Fidelity Extended Market Index (0.01%), Morgan Stanley Pathway Sm-Md Cp Eq ETF (0.01%), Fidelity Series Total Market Index (<0.01%), Fidelity Total Market Index (<0.01%).
What is Indaptus Therapeutics's short interest?
822K shares of Indaptus Therapeutics were sold short, 2.00% of the float; at the average daily volume it would take 0.56 days to cover.
Are insiders buying or selling Indaptus Therapeutics?
Of the latest 2 reported insider transactions in Indaptus Therapeutics (since August 10, 2023), 2 were purchases and 0 were sales.
How many shares of Indaptus Therapeutics are outstanding?
Indaptus Therapeutics has 133.2M shares outstanding, of which 23.7M are in the public float.